petosemtamab
merus
['petosemtamab', 'merus ']
the interim data presented today at #aacr23 highlights clinically meaningful activity of petosemtamab monotherapy observed in previously treated #hnscc #closeinoncancer 
Clinical-stage oncology company developing Biclonics® bispecific antibody therapeutics. Please see our Community Guidelines: https://t.co/qN9crK04bE